Dr. Sakoulas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2001 4th Ave
San Diego, CA 92101Phone+1 619-446-1727Fax+1 858-616-8090
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1999 - 2002- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1999
Harvard Medical SchoolClass of 1995
Certifications & Licensure
CA State Medical License 2007 - 2025
MA State Medical License 1997 - 2012
NY State Medical License 2002 - 2011- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 8 citationsGenetic Determinants Enabling Medium-Dependent Adaptation to Nafcillin in Methicillin-Resistant Staphylococcus aureus.Michael J. Salazar, Henrique Machado, Nicholas Dillon, Hannah Tsunemoto, Richard Szubin
Msystems. 2020-03-31 - 44 citationsStandard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophiliaMonika Kumaraswamy, Leo Lin, Joshua Olson, Ching-Fang Sun, Poochit Nonejuie
The Journal of Antimicrobial Chemotherapy. 2016-05-01 - 8 citationsBacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant Staphylococcus aureusMonika Kumaraswamy, Kamilla Wiull, Bishnu Joshi, George Sakoulas, Armin Kousha
Microorganisms. 2021-09-29
Authored Content
- Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
- Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
- Another Look at Antimicrobial Prophylaxis for Dental Procedures in Patients with Prosthetic Heart ValvesOctober 2017
Press Mentions
04 Dec COVID-19: IVIG Reduced Progression to Ventilator and Shortened Hospital Stays in Sicker PatientsDecember 4th, 2020- Octapharma USA Presents Results of Investigational Use of Octagam® 10% for Severe COVID-19 Patients at ASH Annual MeetingDecember 2nd, 2020
- Intravenous Immunoglobulin Significantly Reduces Respiratory Morbidity in COVID-19 Study Supported by OctapharmaSeptember 9th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
